Your browser doesn't support javascript.
loading
Gankyrin as a potential therapeutic target for cancer.
Wang, Chongchong; Cheng, Li.
Afiliación
  • Wang C; Department of Oncology, the Fourth Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230022, China.
  • Cheng L; Department of Orthopaedics, the Second Affiliated Hospital of Anhui Medical University, Anhui Medical University, 678 Fu Rong Road, Hefei, Anhui Province, 230601, China. aydtgzy@163.com.
Invest New Drugs ; 35(5): 655-661, 2017 Oct.
Article en En | MEDLINE | ID: mdl-28527132
ABSTRACT
Gankyrin is an oncoprotein that plays a central role in the development of cancer. Although researchers have increasingly focused on the relationships of gankyrin with carcinogenesis, metastasis and prognosis of different cancers, the molecular mechanisms are still unclear. In recent years, several interacting partners of gankyrin and cell signaling pathways regulated by gankyrin have been elucidated. In addition, accumulating evidence has indicated the contribution of microRNAs to regulating gankyrin expression in tumor cells. In this review, we summarize the major known roles of gankyrin in cancer cells and highlight the potential clinical relevance of targeting gankyrin. Graphical abstract ᅟ.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Invest New Drugs Año: 2017 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Invest New Drugs Año: 2017 Tipo del documento: Article País de afiliación: China